LYTTON LAURENCE W 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 3:58 pm Purchase |
2024-09-30 | 13G | scPharmaceuticals Inc. SCPH |
LYTTON LAURENCE W | 2,944,932 5.900% |
1,119,698![]() (+61.35%) |
Filing |
2024-04-29 2:34 pm Purchase |
2024-04-17 | 13G | scPharmaceuticals Inc. SCPH |
LYTTON LAURENCE W | 1,825,234 5.100% |
1,825,234![]() (New Position) |
Filing |